Investopedia: Can Body Sculpting Bulk Up Solta Medical?

Most investors are probably aware that the healthcare industry slowed significantly during the recession and has been very slow in coming back. Hospitals have pulled back on capital spending and procedure counts have dropped as would-be patients worry about inadequate insurance coverage, higher co-pays and/or the opportunity to take time off for recuperation.

There's another segment of the healthcare industry, though; one built around elective procedures that is generally not covered by health insurance. Aesthetics is a big part of this segment, and the market for skin tightening, rejuvenation and so on nearly collapsed in the recession. Procedure counts are starting to come back, though, and Solta Medical (Nasdaq:SLTM) is a risky name worth checking out by virtue of its differentiated business model and new LipoSonix body-sculpting line.

Follow this link for more:
http://stocks.investopedia.com/stock-analysis/2012/Can-Body-Sculpting-Bulk-Up-Solta-Medical-SLTM-ZLTQ-MRX-ELOS-PMTI0629.aspx